Prestige Consumer Healthcare (PBH) Stock Overview
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PBH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Prestige Consumer Healthcare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$62.09 |
| 52 Week High | US$90.04 |
| 52 Week Low | US$60.15 |
| Beta | 0.44 |
| 1 Month Change | -2.71% |
| 3 Month Change | -18.05% |
| 1 Year Change | -14.42% |
| 3 Year Change | 18.49% |
| 5 Year Change | 81.71% |
| Change since IPO | 249.80% |
Recent News & Updates
Prestige Consumer Healthcare: Elevated Debt And Limited Growth Prospects
Sep 04Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Price Is Out Of Tune With Earnings
Aug 04
Recent updates
Prestige Consumer Healthcare: Elevated Debt And Limited Growth Prospects
Sep 04Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Price Is Out Of Tune With Earnings
Aug 04Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jul 17These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Reasonably Well
May 09Prestige Consumer Healthcare Inc. (NYSE:PBH) Investors Are Less Pessimistic Than Expected
Apr 16Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 70% Above Its Share Price
Mar 05Results: Prestige Consumer Healthcare Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 09Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Feb 07Pinning Down Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Is Difficult Right Now
Jan 16Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 45% Below Their Intrinsic Value Estimate
Dec 04We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt
Nov 03Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing
Sep 10
Brand Building And Innovations Propel Long-Term Growth Amid Supply Chain Challenges
Investments in brand building and marketing for key products like Hydralyte and Summer's Eve are enhancing consumer awareness and driving revenue growth.Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly
Jul 16Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)
May 22Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Mar 26An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued
Mar 05Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Feb 11Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon
Feb 05Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Dec 14Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly
Sep 10Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation
Aug 15Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?
Jun 12An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued
May 20Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors
Mar 17Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Mar 02Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price
Feb 08Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance
Feb 02Prestige Consumer Healthcare: Taking My Winnings Off The Table
Jan 19Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly
Nov 23Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M
Nov 03Holding Prestige Consumer Healthcare
Aug 31If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity
Aug 26We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt
Aug 05Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M
Aug 04Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?
May 27Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?
May 05Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?
Feb 22Shareholder Returns
| PBH | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 1.8% | -1.3% | 1.7% |
| 1Y | -14.4% | -7.5% | 14.5% |
Return vs Industry: PBH underperformed the US Pharmaceuticals industry which returned -7.5% over the past year.
Return vs Market: PBH underperformed the US Market which returned 14.5% over the past year.
Price Volatility
| PBH volatility | |
|---|---|
| PBH Average Weekly Movement | 4.0% |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PBH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: PBH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 600 | Ron Lombardi | www.prestigebrands.com |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name.
Prestige Consumer Healthcare Inc. Fundamentals Summary
| PBH fundamental statistics | |
|---|---|
| Market cap | US$3.04b |
| Earnings (TTM) | US$213.00m |
| Revenue (TTM) | US$1.12b |
Is PBH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PBH income statement (TTM) | |
|---|---|
| Revenue | US$1.12b |
| Cost of Revenue | US$482.43m |
| Gross Profit | US$637.72m |
| Other Expenses | US$424.71m |
| Earnings | US$213.00m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 06, 2025
| Earnings per share (EPS) | 4.33 |
| Gross Margin | 56.93% |
| Net Profit Margin | 19.02% |
| Debt/Equity Ratio | 53.5% |
How did PBH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/17 20:53 |
| End of Day Share Price | 2025/10/17 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Prestige Consumer Healthcare Inc. is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Olivia Tong Cheang | BofA Global Research |
| Linda Bolton-Weiser | B. Riley Securities, Inc. |
| Susan Anderson | Canaccord Genuity |